{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:55:20Z","timestamp":1779256520904,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41417-019-0152-4","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T15:11:38Z","timestamp":1576163498000},"page":"98-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis"],"prefix":"10.1038","volume":"27","author":[{"given":"Juhua","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donglin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiming","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3404-8446","authenticated-orcid":false,"given":"Zhao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunming","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"152_CR1","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-06-4312","volume":"67","author":"S Chu","year":"2007","unstructured":"Chu S, Li L, Singh H, Bhatia R. BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia. Cancer Res. 2007;67:7045\u201353.","journal-title":"Cancer Res"},{"key":"152_CR2","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL. Chronic myeloid leukemia. New Engl J Med. 1999;340:1330\u201340.","journal-title":"New Engl J Med"},{"key":"152_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New Engl J Med. 2001;344:1031\u20137.","journal-title":"New Engl J Med"},{"key":"152_CR4","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1158\/0008-5472.CAN-13-1318","volume":"73","author":"AS Corbin","year":"2013","unstructured":"Corbin AS, O'Hare T, Gu Z, Kraft IL, Eiring AM, Khorashad JS, et al. KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors. Cancer Res. 2013;73:5775\u201386.","journal-title":"Cancer Res"},{"key":"152_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2017-02-734541","volume":"130","author":"J Taylor","year":"2017","unstructured":"Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130:410\u201323.","journal-title":"Blood"},{"key":"152_CR6","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1073\/pnas.1117317109","volume":"109","author":"S Bras","year":"2012","unstructured":"Bras S, Martin-Lanneree S, Gobert V, Auge B, Breig O, Sanial M, et al. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis. Proc Natl Acad Sci USA. 2012;109:4986\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"152_CR7","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1038\/sj.onc.1207661","volume":"23","author":"LN Winteringham","year":"2004","unstructured":"Winteringham LN, Kobelke S, Williams JH, Ingley E, Klinken SP. Myeloid leukemia factor 1 inhibits erythropoietin-induced differentiation, cell cycle exit and p27Kip1 accumulation. Oncogene. 2004;23:5105\u20139.","journal-title":"Oncogene"},{"key":"152_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1006\/geno.1996.0376","volume":"35","author":"MU Kuefer","year":"1996","unstructured":"Kuefer MU, Look AT, Williams DC, Valentine V, Naeve CW, Behm FG, et al. cDNA cloning, tissue distribution, and chromosomal localization of myelodysplasia\/myeloid leukemia factor 2 (MLF2). Genomics. 1996;35:392\u20136.","journal-title":"Genomics"},{"key":"152_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051415","volume":"7","author":"KR Choudhury","year":"2012","unstructured":"Choudhury KR, Raychaudhuri S, Bhattacharyya NP. Identification of HYPK-interacting proteins reveals involvement of HYPK in regulating cell growth, cell cycle, unfolded protein response and cell death. PLoS ONE. 2012;7:e51415.","journal-title":"PLoS ONE"},{"key":"152_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2016.11.008","volume":"82","author":"M Banerjee","year":"2017","unstructured":"Banerjee M, Datta M, Bhattacharyya NP. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors. Int J Biochem Cell Biol. 2017;82:1\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"152_CR11","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.1320769111","volume":"111","author":"B Dave","year":"2014","unstructured":"Dave B, Granados-Principal S, Zhu R, Benz S, Rabizadeh S, Soon-Shiong P, et al. Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling. Proc Natl Acad Sci USA. 2014;111:8838\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"152_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","volume":"80","author":"T Hunter","year":"1995","unstructured":"Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell. 1995;80:225\u201336.","journal-title":"Cell"},{"key":"152_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","volume":"75","author":"AM Pendergast","year":"1993","unstructured":"Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell. 1993;75:175\u201385.","journal-title":"Cell"},{"key":"152_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/leu.2017.267","volume":"32","author":"S Gerboth","year":"2018","unstructured":"Gerboth S, Frittoli E, Palamidessi A, Baltanas FC, Salek M, Rappsilber J, et al. Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis. Leukemia. 2018;32:820\u20137.","journal-title":"Leukemia"},{"key":"152_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1074\/mcp.T500024-MCP200","volume":"5","author":"E Kinoshita","year":"2006","unstructured":"Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol Cell Proteomics. 2006;5:749\u201357.","journal-title":"Mol Cell Proteomics"},{"key":"152_CR16","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2016-12-689109","volume":"129","author":"M de Bruijn","year":"2017","unstructured":"de Bruijn M, Dzierzak E. Runx transcription factors in the development and function of the definitive hematopoietic system. Blood. 2017;129:2061\u20139.","journal-title":"Blood"},{"key":"152_CR17","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1158\/1078-0432.CCR-10-1551","volume":"17","author":"J Yu","year":"2011","unstructured":"Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, et al. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res. 2011;17:1924\u201334.","journal-title":"Clin Cancer Res"},{"key":"152_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006932","volume":"13","author":"M Miller","year":"2017","unstructured":"Miller M, Chen A, Gobert V, Auge B, Beau M, Burlet-Schiltz O, et al. Control of RUNX-induced repression of Notch signaling by MLF and its partner DnaJ-1 during Drosophila hematopoiesis. PLoS Genet. 2017;13:e1006932.","journal-title":"PLoS Genet"},{"key":"152_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1470-2045(00)00256-4","volume":"2","author":"PK Lala","year":"2001","unstructured":"Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2001;2:149\u201356.","journal-title":"Lancet Oncol"},{"key":"152_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073672","volume":"8","author":"AA Chowdhury","year":"2013","unstructured":"Chowdhury AA, Chaudhuri J, Biswas N, Manna A, Chatterjee S, Mahato SK, et al. Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway. PloS ONE. 2013;8:e73672.","journal-title":"PloS ONE"},{"key":"152_CR21","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1182\/blood-2013-12-545640","volume":"124","author":"P Gallipoli","year":"2014","unstructured":"Gallipoli P, Cook A, Rhodes S, Hopcroft L, Wheadon H, Whetton AD, et al. JAK2\/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo. Blood. 2014;124:1492\u2013501.","journal-title":"Blood"},{"key":"152_CR22","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","volume":"72","author":"J Bertacchini","year":"2015","unstructured":"Bertacchini J, Heidari N, Mediani L, Capitani S, Shahjahani M, Ahmadzadeh A, et al. Targeting PI3K\/AKT\/mTOR network for treatment of leukemia. Cell Mol Life Sci. 2015;72:2337\u201347.","journal-title":"Cell Mol Life Sci"},{"key":"152_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/B978-0-12-396456-4.00007-9","volume":"106","author":"WC Juan","year":"2012","unstructured":"Juan WC, Ong ST. The role of protein phosphorylation in therapy resistance and disease progression in chronic myelogenous leukemia. Prog Mol Biol Transl Sci. 2012;106:107\u201342.","journal-title":"Prog Mol Biol Transl Sci"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41417-019-0152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41417-019-0152-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41417-019-0152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:37Z","timestamp":1684617037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-019-0152-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1038\/s41417-019-0152-4","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"20 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}